XML 188 R39.htm IDEA: XBRL DOCUMENT v3.24.4
Stockholders’ (Deficit) Equity (Tables) - Staffing 360 Solutions, Inc. [Member]
9 Months Ended 12 Months Ended
Sep. 28, 2024
Dec. 30, 2023
Class of Stock [Line Items]    
Schedule of Shares Common Stock The Company issued the following shares of common stock during the nine months ended September 28, 2024:

Shares issued to/for:

 

Number of
Common Shares
Issued

 

Fair Value
of Shares
Issued

 

Fair Value at Issuance
(minimum and maximum
per share)

Warrants Exercised

 

433,936

 

$

3,602

 

$

8.30

 

$

8.30

Board and committee members

 

127,000

 

 

545

 

$

0.28

 

$

4.10

   

560,936

 

$

4,147

 

 

   

 

 
The Company issued the following shares of common stock during the nine-months ended September 30, 2023:

Shares issued to/for:

 

Number of
Common Shares
Issued

 

Fair Value
of Shares
Issued

 

Fair Value at Issuance
(minimum and maximum
per share)

Equity raise

 

188,452

 

$

4,999

 

$

26.50

 

$

26.50

Employees

 

17,731

 

 

531

 

$

28.20

 

$

28.20

Board and committee members

 

16,000

 

 

243

 

$

10.50

 

$

31.30

   

222,183

 

$

5,773

 

 

   

 

 
The Company issued the following shares of common stock during the twelve-month period ended December 30, 2023:

Shares issued to/for:

 

Number of
Common Shares
Issued

 

Fair Value
of Shares
Issued

 

Fair Value at Issuance
(minimum and maximum
per share)

Equity raise

 

1,884,516

 

$

4,113

 

$

2.65

 

$

2.65

Employees

 

177,305

 

 

561

 

$

2.82

 

$

2.82

Board and committee members

 

160,000

 

 

155

 

$

3.02

 

$

9.65

Warrants Exercised per inducement letter

 

550,000

 

 

1,994

 

$

0.83

 

$

0.83

Shares issued in connection with debt – related party

 

200,000

 

 

128

 

$

0.64

 

$

0.64

   

2,971,821

 

$

6,951

 

 

   

 

 

Shares issued to/for:

 

Number of
Common Shares
Issued

 

Fair Value
of Shares
Issued

 

Fair Value at Issuance
(minimum and maximum
per share)

Equity raise

 

657,858

 

$

4,013

 

$

6.10

 

$

6.10

Board and committee members

 

63,000

 

 

201

 

 

3.02

 

 

9.65

Related party shares

 

100,000

 

 

257

 

 

2.57

 

 

2.57

Consultants

 

36,000

 

 

113

 

 

3.02

 

 

7.40

   

856,858

 

$

4,584

 

 

   

 

 
Schedule of Unvested Restricted Shares Issued to Employees and Board of Directors The table below is a rollforward of unvested restricted shares issued to employees and board of directors.
 

Restricted
Shares

 

Weighted
Average
Price
Per Share

Outstanding at December 31, 2022

 

6,859

 

 

$

67.20

Granted

 

33,731

 

 

 

23.00

Vested/adjustments

 

(17,769

)

 

 

28.80

Outstanding at December 30, 2023

 

22,821

 

 

 

31.80

Granted

 

 

 

 

Vested/adjustments

 

(262

)

 

 

11.84

Outstanding at September 28, 2024

 

22,559

 

 

$

28.28

The table below is a rollforward of unvested restricted shares issued to employees and board of directors.
 

Restricted
Shares

 

Weighted
Average
Price
Per Share

Outstanding at January 1, 2022

 

5,976

 

 

$

50.00

Granted

 

63,000

 

 

 

3.20

Vested/adjustments

 

(384

)

 

 

88.80

Outstanding at December 31, 2022

 

68,592

 

 

 

6.72

Granted

 

337,305

 

 

 

2.30

Vested/adjustments

 

(177,689

)

 

 

2.88

Balance at December 30, 2023

 

228,208

 

 

$

3.18

Schedule of Warrant Issuance Transactions involving the Company’s warrant issuances are summarized as follows:
 


Number of
Shares

 

Weighted
Average
Exercise Price

Outstanding at December 31, 2022

 

170,369

 

 

$

96.10

Issued

 

863,193

 

 

 

20.59

Exercised

 

(276,117

)

 

 

5.90

Expired or cancelled

 

(87,665

)

 

 

58.50

Outstanding at December 30, 2023

 

669,780

 

 

 

34.80

Issued

 

 

 

 

Exercised

 

(433,936

)

 

 

13.03

Expired or cancelled

 

(138,968

)

 

 

17.18

Outstanding at September 28, 2024

 

96,876

 

 

$

240.77

Transactions involving the Company’s warrant issuances are summarized as follows:
 

Number of
Shares

 

Weighted
Average
Exercise Price

Outstanding at January 1, 2022

 

972,495

 

 

$

26.88

Issued

 

1,404,478

 

 

 

5.83

Exercised

 

 

 

 

Expired or cancelled

 

(673,285

)

 

 

26.84

Outstanding at December 31, 2022

 

1,703,688

 

 

 

9.61

Issued

 

8,631,937

 

 

 

1.40

Exercised

 

(2,761,170

)

 

 

0.59

Expired or cancelled

 

(876,654

)

 

 

5.85

Balance at December 30, 2023

 

6,697,801

 

 

$

3.48

Schedule of Option Activity A summary of option activity during the quarter ended September 28, 2024, is presented below:
 

Options

 

Weighted
Average
Exercise Price

Outstanding at December 31, 2022

 

5,151

 

 

$

500.60

Granted

 

 

 

 

Exercised

 

 

 

 

Expired or cancelled

 

 

 

 

Outstanding at December 30, 2023

 

5,151

 

 

 

500.06

Granted

 

 

 

 

Exercised

 

 

 

 

Expired or cancelled

 

(33

)

 

 

5,303.57

Outstanding at September 28, 2024

 

5,118

 

 

$

498.53

A summary of option activity during Fiscal 2023 and Fiscal 2022 of the Company’s 2014 Equity Incentive Plan, 2015 Omnibus Incentive Plan and the 2016 Omnibus Incentive Plan is presented below:
 

Options

 

Weighted
Average
Exercise Price

Outstanding at January 1, 2022

 

1,302

 

$

1,665.60

Granted

 

50,000

 

 

7.80

Exercised

 

 

 

Expired or cancelled

 

 

 

Outstanding at December 31, 2022

 

51,302

 

 

50.06

Granted

 

 

 

Exercised

 

 

 

Expired or cancelled

 

 

 

Balance at December 30, 2023

 

51,302

 

$

50.06

Warrant [Member]    
Class of Stock [Line Items]    
Schedule of Warrants Outstanding The following table summarizes warrants outstanding as of September 28, 2024:

Exercise Price

 

Number
Outstanding
and Exercisable

 

Weighted
Average
Remaining
Contractual
Life (years)

 

Weighted
Average
Exercise price

$24.70 – $3,000.00

 

96,876

 

2.88

 

$

240.77

The following table summarizes warrants outstanding as of December 30, 2023:

Exercise Price

 

Number
Outstanding
and Exercisable

 

Weighted
Average
Remaining
Contractual
Life (years)

 

Weighted
Average
Exercise price

$3.06 – $3,750.00

 

6,697,801

 

3.41

 

$

3.48